Clinical Trial Update: IN10018 Combination Therapy in Treatment-naïve ES-SCLC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for IN10018 combination therapy in treatment-naïve extensive-stage small cell lung cancer. The study is in Phase 1 and Phase 2 and is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• IN10018

Snippet

Sponsor: InxMed (Shanghai) Co., Ltd. | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 1, Phase 2 | Status: RECRUITING